Virtus LifeSci Biotech Products ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BBP and other ETFs, options, and stocks.

About BBP

BBP tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. 

Index-Tracked
FT Wilshire 5000 TR USD
Index-TrackedFT Wilshire 5000 TR USD
Category
Health
CategoryHealth
Number of holdings
57
Number of holdings57
Inception Date
Dec 16, 2014
Inception DateDec 16, 2014

BBP Key Statistics

AUM
31.52M
AUM31.52M
Price-Earnings ratio
-78.72
Price-Earnings ratio-78.72
30-Day yield
30-Day yield
Average volume
4.41K
Average volume4.41K
High today
$79.24
High today$79.24
Low today
$78.06
Low today$78.06
Open price
$79.24
Open price$79.24
Volume
7.47K
Volume7.47K
52 Week high
$80.54
52 Week high$80.54
52 Week low
$48.65
52 Week low$48.65
Expense ratio
0.79
Expense ratio0.79

Stock Snapshot

As of today, Virtus LifeSci Biotech Products ETF(BBP) shares are valued at $78.12. The company's market cap stands at 31.52M, with a P/E ratio of -78.72 and a dividend yield of 9.2%.

On 2025-12-13, Virtus LifeSci Biotech Products ETF(BBP) stock traded between a low of $78.06 and a high of $79.24. Shares are currently priced at $78.12, which is +0.1% above the low and -1.4% below the high.

The Virtus LifeSci Biotech Products ETF(BBP)'s current trading volume is 7.47K, compared to an average daily volume of 4.41K.

In the last year, Virtus LifeSci Biotech Products ETF(BBP) shares hit a 52-week high of $80.54 and a 52-week low of $48.65.

In the last year, Virtus LifeSci Biotech Products ETF(BBP) shares hit a 52-week high of $80.54 and a 52-week low of $48.65.

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.